Clevidipine: a novel ultra-short-acting calcium antagonist.

  title={Clevidipine: a novel ultra-short-acting calcium antagonist.},
  author={Lendita Prlesi and Angela Cheng-Lai},
  journal={Cardiology in review},
  volume={17 3},
Hypertension is the most common cardiovascular condition in the United States. It can lead to end organ damage and increased mortality risk if it is not properly controlled. In most situations where blood pressure has to be brought down quickly, an intravenous agent with a quick onset of action is often used. Clevidipine is the first third-generation IV dihydropyridine calcium channel blocker that has a high degree of vascular selectivity and an ultra-fast onset and offset of blood pressure… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS